Seller record · Telehealth service

Elara MD

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S4, compounding disclosure: The personalized GLP-1/GIP page invokes Section 503A and says it is not a substitute for FDA-approved products, but the public product pages do not plainly say that the compounded preparations are not FDA-approved. 2 more criteria also fail; see the table below.

At a glance

Elara MDTelehealth service

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: GLP-1 program, GLP-1/GIP with B12, sermorelin, and 1 more
FDA letters: None on file

Visit Elara MD See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth wellness platform offering personalized GLP-1 programs and injectable or troche sermorelin, with a licensed-provider evaluation and pharmacy shipment following approval.

Operating entity The company, contact, terms and privacy pages identify the service as Elara MD without a separate legal entity name.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Elara MD's about page; Elara MD's GLP-1 GIP page
S2	Prescription gating	PASS	Elara MD's about page; Elara MD's FAQ
S3	Pharmacy identification	PASS	Elara MD's FAQ
S4	Compounding disclosure	FAIL	Elara MD's GLP-1 GIP page; Elara MD's GLP-1 page; Elara MD's sermorelin page
S5	Analytical documentation	FAIL	Elara MD's GLP-1 page; Elara MD's sermorelin page; Elara MD's FAQ
S6	Business address	FAIL	Elara MD's contact page; Elara MD's about page; Elara MD's terms of use page; Elara MD's FAQ
S7	Price disclosure	PASS	Elara MD's GLP-1 page; Elara MD's sermorelin page; Elara MD's sermorelin troches page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe company page says every program begins with a licensed provider evaluation, and the GLP-1/GIP product requires a patient-specific prescription.Source: Elara MD's about page; Elara MD's GLP-1 GIP page.

S2PASSEvery program begins with a provider evaluation, and the FAQ states that medication is billed when it ships.Source: Elara MD's about page; Elara MD's FAQ.

S3PASSThe FAQ names Strive Pharmacy at 275 E Baseline Rd #104, Gilbert, AZ 85233.Source: Elara MD's FAQ.

S4FAILThe personalized GLP-1/GIP page invokes Section 503A and says it is not a substitute for FDA-approved products, but the public product pages do not plainly say that the compounded preparations are not FDA-approved.Source: Elara MD's GLP-1 GIP page; Elara MD's GLP-1 page; Elara MD's sermorelin page.

S5FAILNo certificate of analysis or equivalent lot document is published on the GLP-1, sermorelin or FAQ pages.Source: Elara MD's GLP-1 page; Elara MD's sermorelin page; Elara MD's FAQ.

S6FAILThe contact, company and policy pages do not publish a postal address for Elara MD. The FAQ pharmacy address and medical-board addresses in the terms belong to other organizations.Source: Elara MD's contact page; Elara MD's about page; Elara MD's terms of use page; Elara MD's FAQ.

S7PASSThe GLP-1 program starts at $199 a month. Injectable sermorelin starts at $349 a month, while the sermorelin mini-troche page lists $249 for the starting dose.Source: Elara MD's GLP-1 page; Elara MD's sermorelin page; Elara MD's sermorelin troches page.

S8PASSNo FDA warning letter names Elara MD, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: GLP-1 program, GLP-1/GIP with B12, sermorelin, sermorelin troches.

Other sellers of the same products

Who sells sermorelin

Visit Elara MD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.